 |
 |

Levodopa-Induced Postural HypotensionTreatment With Fludrocortisone
Margaret M. Hoehn, MD, FRCP(C)
Arch Neurol. 1975;32(1):50-51.
Abstract
Six parkinsonian patients with symptomatic postural hypotension secondary to levodopa therapy were treated with 0.05 to 0.2 mg of fludrocortisone acetate daily for six to ten months. Severe orthostatic light-headedness and frequent syncope had previously been alleviated only by reducing the dosage of levodopa to levels producing less than optimal antiparkinsonian benefits. In all six patients, symptoms were alleviated satisfactorily, and supine and upright blood pressures returned to normal levels during treatment with fludrocortisone acetate. There were no adverse reactions. Fludrocortisone acetate is an effective and safe drug for the treatment of severe and otherwise intractable postural hypotension secondary to therapy with levodopa.
Author Affiliations
From the Department of Neurology, University of Colorado Medical Center, Denver.
Footnotes
Accepted for publication July 16, 1974.
Reprint requests to Box 116, University of Colorado Medical Center, 4200 E Ninth Ave, Denver, CO 80220 (Dr. Hoehn).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Neurocirculatory Abnormalities in Parkinson Disease With Orthostatic Hypotension: Independence From Levodopa Treatment
Goldstein et al.
Hypertension 2005;46:1333-1339.
ABSTRACT
| FULL TEXT
Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure
Goldstein et al.
Hypertension 2003;42:136-142.
ABSTRACT
| FULL TEXT
Orthostatic hypotension from sympathetic denervation in Parkinson's disease
Goldstein et al.
Neurology 2002;58:1247-1255.
ABSTRACT
| FULL TEXT
Cardiac Sympathetic Denervation in Parkinson Disease
Goldstein et al.
ANN INTERN MED 2000;133:338-347.
ABSTRACT
| FULL TEXT
|